CN Stock MarketDetailed Quotes

002653 Haisco Pharmaceutical Group

Watchlist
  • 34.60
  • -0.20-0.57%
Market Closed Dec 20 15:00 CST
38.75BMarket Cap81.41P/E (TTM)

Haisco Pharmaceutical Group Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

All
YOY yoy
Hide blank lines yoy
(Q9)Sep 30, 2024
(Q6)Jun 30, 2024
(Q3)Mar 31, 2024
(FY)Dec 31, 2023
(Q9)Sep 30, 2023
(Q6)Jun 30, 2023
(Q3)Mar 31, 2023
(FY)Dec 31, 2022
(Q9)Sep 30, 2022
(Q6)Jun 30, 2022
Total operating revenue
15.41%2.75B
23.14%1.69B
20.60%752.13M
11.27%3.36B
13.70%2.38B
9.81%1.37B
10.97%623.64M
8.73%3.02B
9.71%2.1B
-2.26%1.25B
Operating revenue
15.41%2.75B
23.14%1.69B
20.60%752.13M
11.27%3.36B
13.70%2.38B
9.81%1.37B
10.97%623.64M
8.73%3.02B
9.71%2.1B
-2.26%1.25B
Other operating revenue
----
48.04%13.49M
----
17.06%19.94M
----
15.70%9.11M
----
101.41%17.03M
----
537.14%7.88M
Total operating cost
9.89%2.44B
15.03%1.5B
16.48%690.69M
5.99%3.08B
9.87%2.22B
8.92%1.3B
8.76%592.95M
5.61%2.91B
3.43%2.02B
-5.76%1.19B
Operating cost
9.34%755.06M
20.27%473.1M
38.49%234.85M
5.78%972.43M
2.52%690.55M
1.49%393.38M
-0.36%169.58M
-2.56%919.28M
-3.16%673.59M
-14.64%387.58M
Operating tax surcharges
11.46%36.29M
18.71%22.28M
21.45%9.79M
41.10%50.54M
39.47%32.56M
28.51%18.77M
10.96%8.06M
36.29%35.82M
52.50%23.34M
56.53%14.61M
Operating expense
13.06%969.57M
21.46%590.4M
18.16%267.81M
5.65%1.2B
9.67%857.56M
9.64%486.06M
14.84%226.65M
16.37%1.14B
14.37%781.94M
2.39%443.32M
Administration expense
3.68%286.75M
6.05%188.45M
4.34%90.73M
-2.08%320.91M
18.66%276.58M
18.28%177.71M
20.00%86.96M
-6.84%327.71M
-9.92%233.08M
-10.39%150.24M
Financial expense
-41.97%10.19M
-56.82%6.23M
-60.73%4M
-45.58%23.47M
-37.54%17.56M
-17.21%14.43M
-15.11%10.18M
84.62%43.13M
106.16%28.11M
112.84%17.43M
-Interest expense (Financial expense)
-10.06%28.88M
-21.51%18.33M
-26.03%9.26M
-16.96%42.28M
-8.59%32.11M
13.02%23.36M
2.81%12.52M
87.48%50.91M
119.20%35.13M
140.76%20.66M
-Interest Income (Financial expense)
-22.42%-18.36M
-38.77%-12.68M
-234.34%-4.94M
-151.40%-19.33M
-178.28%-15M
-224.54%-9.14M
-21.98%-1.48M
-37.73%-7.69M
-26.55%-5.39M
-4.41%-2.82M
Research and development
10.61%377.97M
2.48%214.66M
-8.74%83.51M
15.36%516.67M
23.19%341.72M
16.24%209.47M
6.51%91.51M
3.16%447.87M
-2.16%277.39M
-7.18%180.22M
Credit Impairment Loss
-182.13%-2.58M
-17,971.59%-518.79K
60.22%423.58K
-175.12%-825.02K
-762.23%-914.81K
-100.24%-2.87K
-58.67%264.37K
445.73%1.1M
209.17%138.14K
48.16%1.21M
Asset Impairment Loss
-18,574.13%-52.02M
-5,343.98%-54.01M
-192.71%-1.02M
-69.09%-10.13M
104.63%281.57K
114.91%1.03M
149.57%1.1M
-73.11%-5.99M
-1,551.30%-6.09M
-1,747.56%-6.91M
Other net revenue
474.23%187.69M
284.66%15.14M
928.72%36.45M
-83.45%42.87M
591.53%32.68M
-254.58%-8.2M
-152.22%-4.4M
-47.57%259.12M
-99.01%4.73M
-98.88%5.3M
Fair value change income
--108.06K
--20.83K
--50.69K
--55.56K
----
----
--0
----
----
----
Invest income
442.91%124.87M
-134.75%-42.59M
-318.60%-39.82M
-126.58%-60.53M
-160.78%-36.42M
-134.53%-18.14M
-375.03%-9.51M
-45.88%227.72M
-103.40%-13.96M
-101.88%-7.74M
-Including: Investment income associates
-9.88%-42.55M
-122.53%-43.58M
-316.02%-39.98M
-77.00%-63.65M
-172.97%-38.72M
-146.09%-19.58M
-346.57%-9.61M
-2,068.91%-35.96M
-1,089.51%-14.19M
-797.52%-7.96M
Asset deal income
3,241.19%24.75M
379,601.08%24.81M
-13.56%75.55K
-9,125.81%-284.33K
-1,782.27%-787.81K
96.48%-6.54K
621.61%87.4K
97.63%-3.08K
78.53%-41.85K
-67.72%-185.69K
Other revenue
31.24%92.56M
879.26%87.43M
1,994.82%76.74M
215.74%114.58M
185.75%70.52M
-52.83%8.93M
-60.75%3.66M
-52.79%36.29M
-63.43%24.68M
-69.74%18.93M
Operating profit
151.42%503.1M
235.07%206.65M
272.31%97.89M
-13.97%313.53M
138.09%200.1M
4.09%61.67M
4.20%26.29M
-28.86%364.44M
-80.85%84.05M
-87.79%59.25M
Add:Non operating Income
22.77%1.17M
69.24%940.62K
-11.12%375.85K
-79.69%1.49M
-77.47%954.29K
-83.67%555.81K
72.35%422.9K
-33.24%7.34M
-11.69%4.24M
4.67%3.4M
Less:Non operating expense
357.18%23.4M
259.10%10.03M
84.54%2.08M
141.69%12.5M
52.94%5.12M
57.28%2.79M
-1.07%1.13M
-58.67%5.17M
-70.16%3.35M
-55.10%1.78M
Total profit
145.42%480.87M
232.39%197.56M
275.91%96.19M
-17.48%302.52M
130.69%195.94M
-2.36%59.44M
5.13%25.59M
-28.22%366.61M
-80.36%84.94M
-87.43%60.88M
Less:Income tax cost
649.70%28.86M
383.05%34.55M
294.56%5.47M
127.73%6.96M
70.10%-5.25M
-35.63%-12.21M
-20.58%-2.81M
-266.89%-25.1M
-79.71%-17.56M
-179.63%-9M
Net profit
124.67%452.01M
127.53%163.01M
219.46%90.72M
-24.55%295.56M
96.29%201.19M
2.53%71.64M
6.48%28.4M
-24.32%391.71M
-76.82%102.5M
-85.67%69.88M
Net profit from continuing operation
124.67%452.01M
127.53%163.01M
219.46%90.72M
-24.55%295.56M
96.29%201.19M
2.53%71.64M
6.48%28.4M
-24.32%391.71M
-76.82%102.5M
-85.67%69.88M
Less:Minority Profit
15,594.10%70.19M
50.24%-1.71M
-251.91%-1.24M
-99.61%451.22K
180.67%447.26K
-6,447.12%-3.43M
-175.52%-351.49K
-33.55%114.64M
-100.33%-554.43K
-99.97%54.07K
Net profit of parent company owners
90.20%381.82M
119.40%164.72M
219.86%91.96M
6.51%295.11M
94.80%200.74M
7.52%75.08M
9.72%28.75M
-19.70%277.07M
-62.54%103.05M
-78.20%69.82M
Earning per share
Basic earning per share
88.13%0.3409
118.11%0.1481
166.67%0.08
3.85%0.27
89.14%0.1812
4.62%0.0679
50.00%0.03
-18.75%0.26
-62.59%0.0958
-78.24%0.0649
Diluted earning per share
88.13%0.3409
118.11%0.1481
166.67%0.08
3.85%0.27
89.14%0.1812
4.62%0.0679
50.00%0.03
-18.75%0.26
-62.59%0.0958
-78.24%0.0649
Other composite income
96.54%-1.81M
-69.33%7.18M
-67.22%18.28M
-49.72%48.55M
-175.73%-52.19M
-79.44%23.4M
279.19%55.77M
655.11%96.56M
1,910.21%68.91M
3,003.12%113.82M
Other composite income of parent company owners
96.70%-1.79M
-67.68%6.55M
-68.64%17.8M
-47.98%46.52M
-183.98%-54.11M
-81.78%20.27M
283.91%56.76M
620.86%89.43M
1,568.24%64.43M
2,745.39%111.22M
Other composite income of minority owners
-101.01%-19.44K
-79.96%628.16K
148.95%482.1K
-71.51%2.03M
-57.05%1.92M
20.50%3.13M
-275.11%-984.88K
3,275.72%7.13M
670.36%4.48M
816.87%2.6M
Total composite income
202.15%450.21M
79.06%170.19M
29.50%109M
-29.52%344.11M
-13.07%149M
-48.26%95.05M
1,988.98%84.17M
-2.38%488.27M
-60.90%171.41M
-62.02%183.7M
Total composite income of parent company owners
159.18%380.03M
79.63%171.27M
28.36%109.76M
-6.79%341.63M
-12.45%146.63M
-47.34%95.34M
1,935.41%85.51M
11.78%366.5M
-38.13%167.49M
-42.72%181.05M
Total composite income of minority owners
2,859.09%70.17M
-262.76%-1.08M
43.52%-754.83K
-97.96%2.48M
-39.59%2.37M
-111.21%-297.61K
-758.72%-1.34M
-29.33%121.77M
-97.66%3.93M
-98.42%2.65M
Currency Unit
CNY
CNY
CNY
CNY
CNY
CNY
CNY
CNY
CNY
CNY
Accounting Standards
CAS (2007)
CAS (2007)
CAS (2007)
CAS (2007)
CAS (2007)
CAS (2007)
CAS (2007)
CAS (2007)
CAS (2007)
CAS (2007)
Audit Opinions
--
--
--
Unqualified opinion
--
--
--
Unqualified opinion
--
--
Auditor
--
--
--
Shinaga Zhonghe Certified Public Accountants Co., Ltd. (Special General Partnership)
--
--
--
Shinaga Zhonghe Certified Public Accountants Co., Ltd. (Special General Partnership)
--
--
(Q9)Sep 30, 2024(Q6)Jun 30, 2024(Q3)Mar 31, 2024(FY)Dec 31, 2023(Q9)Sep 30, 2023(Q6)Jun 30, 2023(Q3)Mar 31, 2023(FY)Dec 31, 2022(Q9)Sep 30, 2022(Q6)Jun 30, 2022
Total operating revenue 15.41%2.75B23.14%1.69B20.60%752.13M11.27%3.36B13.70%2.38B9.81%1.37B10.97%623.64M8.73%3.02B9.71%2.1B-2.26%1.25B
Operating revenue 15.41%2.75B23.14%1.69B20.60%752.13M11.27%3.36B13.70%2.38B9.81%1.37B10.97%623.64M8.73%3.02B9.71%2.1B-2.26%1.25B
Other operating revenue ----48.04%13.49M----17.06%19.94M----15.70%9.11M----101.41%17.03M----537.14%7.88M
Total operating cost 9.89%2.44B15.03%1.5B16.48%690.69M5.99%3.08B9.87%2.22B8.92%1.3B8.76%592.95M5.61%2.91B3.43%2.02B-5.76%1.19B
Operating cost 9.34%755.06M20.27%473.1M38.49%234.85M5.78%972.43M2.52%690.55M1.49%393.38M-0.36%169.58M-2.56%919.28M-3.16%673.59M-14.64%387.58M
Operating tax surcharges 11.46%36.29M18.71%22.28M21.45%9.79M41.10%50.54M39.47%32.56M28.51%18.77M10.96%8.06M36.29%35.82M52.50%23.34M56.53%14.61M
Operating expense 13.06%969.57M21.46%590.4M18.16%267.81M5.65%1.2B9.67%857.56M9.64%486.06M14.84%226.65M16.37%1.14B14.37%781.94M2.39%443.32M
Administration expense 3.68%286.75M6.05%188.45M4.34%90.73M-2.08%320.91M18.66%276.58M18.28%177.71M20.00%86.96M-6.84%327.71M-9.92%233.08M-10.39%150.24M
Financial expense -41.97%10.19M-56.82%6.23M-60.73%4M-45.58%23.47M-37.54%17.56M-17.21%14.43M-15.11%10.18M84.62%43.13M106.16%28.11M112.84%17.43M
-Interest expense (Financial expense) -10.06%28.88M-21.51%18.33M-26.03%9.26M-16.96%42.28M-8.59%32.11M13.02%23.36M2.81%12.52M87.48%50.91M119.20%35.13M140.76%20.66M
-Interest Income (Financial expense) -22.42%-18.36M-38.77%-12.68M-234.34%-4.94M-151.40%-19.33M-178.28%-15M-224.54%-9.14M-21.98%-1.48M-37.73%-7.69M-26.55%-5.39M-4.41%-2.82M
Research and development 10.61%377.97M2.48%214.66M-8.74%83.51M15.36%516.67M23.19%341.72M16.24%209.47M6.51%91.51M3.16%447.87M-2.16%277.39M-7.18%180.22M
Credit Impairment Loss -182.13%-2.58M-17,971.59%-518.79K60.22%423.58K-175.12%-825.02K-762.23%-914.81K-100.24%-2.87K-58.67%264.37K445.73%1.1M209.17%138.14K48.16%1.21M
Asset Impairment Loss -18,574.13%-52.02M-5,343.98%-54.01M-192.71%-1.02M-69.09%-10.13M104.63%281.57K114.91%1.03M149.57%1.1M-73.11%-5.99M-1,551.30%-6.09M-1,747.56%-6.91M
Other net revenue 474.23%187.69M284.66%15.14M928.72%36.45M-83.45%42.87M591.53%32.68M-254.58%-8.2M-152.22%-4.4M-47.57%259.12M-99.01%4.73M-98.88%5.3M
Fair value change income --108.06K--20.83K--50.69K--55.56K----------0------------
Invest income 442.91%124.87M-134.75%-42.59M-318.60%-39.82M-126.58%-60.53M-160.78%-36.42M-134.53%-18.14M-375.03%-9.51M-45.88%227.72M-103.40%-13.96M-101.88%-7.74M
-Including: Investment income associates -9.88%-42.55M-122.53%-43.58M-316.02%-39.98M-77.00%-63.65M-172.97%-38.72M-146.09%-19.58M-346.57%-9.61M-2,068.91%-35.96M-1,089.51%-14.19M-797.52%-7.96M
Asset deal income 3,241.19%24.75M379,601.08%24.81M-13.56%75.55K-9,125.81%-284.33K-1,782.27%-787.81K96.48%-6.54K621.61%87.4K97.63%-3.08K78.53%-41.85K-67.72%-185.69K
Other revenue 31.24%92.56M879.26%87.43M1,994.82%76.74M215.74%114.58M185.75%70.52M-52.83%8.93M-60.75%3.66M-52.79%36.29M-63.43%24.68M-69.74%18.93M
Operating profit 151.42%503.1M235.07%206.65M272.31%97.89M-13.97%313.53M138.09%200.1M4.09%61.67M4.20%26.29M-28.86%364.44M-80.85%84.05M-87.79%59.25M
Add:Non operating Income 22.77%1.17M69.24%940.62K-11.12%375.85K-79.69%1.49M-77.47%954.29K-83.67%555.81K72.35%422.9K-33.24%7.34M-11.69%4.24M4.67%3.4M
Less:Non operating expense 357.18%23.4M259.10%10.03M84.54%2.08M141.69%12.5M52.94%5.12M57.28%2.79M-1.07%1.13M-58.67%5.17M-70.16%3.35M-55.10%1.78M
Total profit 145.42%480.87M232.39%197.56M275.91%96.19M-17.48%302.52M130.69%195.94M-2.36%59.44M5.13%25.59M-28.22%366.61M-80.36%84.94M-87.43%60.88M
Less:Income tax cost 649.70%28.86M383.05%34.55M294.56%5.47M127.73%6.96M70.10%-5.25M-35.63%-12.21M-20.58%-2.81M-266.89%-25.1M-79.71%-17.56M-179.63%-9M
Net profit 124.67%452.01M127.53%163.01M219.46%90.72M-24.55%295.56M96.29%201.19M2.53%71.64M6.48%28.4M-24.32%391.71M-76.82%102.5M-85.67%69.88M
Net profit from continuing operation 124.67%452.01M127.53%163.01M219.46%90.72M-24.55%295.56M96.29%201.19M2.53%71.64M6.48%28.4M-24.32%391.71M-76.82%102.5M-85.67%69.88M
Less:Minority Profit 15,594.10%70.19M50.24%-1.71M-251.91%-1.24M-99.61%451.22K180.67%447.26K-6,447.12%-3.43M-175.52%-351.49K-33.55%114.64M-100.33%-554.43K-99.97%54.07K
Net profit of parent company owners 90.20%381.82M119.40%164.72M219.86%91.96M6.51%295.11M94.80%200.74M7.52%75.08M9.72%28.75M-19.70%277.07M-62.54%103.05M-78.20%69.82M
Earning per share
Basic earning per share 88.13%0.3409118.11%0.1481166.67%0.083.85%0.2789.14%0.18124.62%0.067950.00%0.03-18.75%0.26-62.59%0.0958-78.24%0.0649
Diluted earning per share 88.13%0.3409118.11%0.1481166.67%0.083.85%0.2789.14%0.18124.62%0.067950.00%0.03-18.75%0.26-62.59%0.0958-78.24%0.0649
Other composite income 96.54%-1.81M-69.33%7.18M-67.22%18.28M-49.72%48.55M-175.73%-52.19M-79.44%23.4M279.19%55.77M655.11%96.56M1,910.21%68.91M3,003.12%113.82M
Other composite income of parent company owners 96.70%-1.79M-67.68%6.55M-68.64%17.8M-47.98%46.52M-183.98%-54.11M-81.78%20.27M283.91%56.76M620.86%89.43M1,568.24%64.43M2,745.39%111.22M
Other composite income of minority owners -101.01%-19.44K-79.96%628.16K148.95%482.1K-71.51%2.03M-57.05%1.92M20.50%3.13M-275.11%-984.88K3,275.72%7.13M670.36%4.48M816.87%2.6M
Total composite income 202.15%450.21M79.06%170.19M29.50%109M-29.52%344.11M-13.07%149M-48.26%95.05M1,988.98%84.17M-2.38%488.27M-60.90%171.41M-62.02%183.7M
Total composite income of parent company owners 159.18%380.03M79.63%171.27M28.36%109.76M-6.79%341.63M-12.45%146.63M-47.34%95.34M1,935.41%85.51M11.78%366.5M-38.13%167.49M-42.72%181.05M
Total composite income of minority owners 2,859.09%70.17M-262.76%-1.08M43.52%-754.83K-97.96%2.48M-39.59%2.37M-111.21%-297.61K-758.72%-1.34M-29.33%121.77M-97.66%3.93M-98.42%2.65M
Currency Unit CNYCNYCNYCNYCNYCNYCNYCNYCNYCNY
Accounting Standards CAS (2007)CAS (2007)CAS (2007)CAS (2007)CAS (2007)CAS (2007)CAS (2007)CAS (2007)CAS (2007)CAS (2007)
Audit Opinions ------Unqualified opinion------Unqualified opinion----
Auditor ------Shinaga Zhonghe Certified Public Accountants Co., Ltd. (Special General Partnership)------Shinaga Zhonghe Certified Public Accountants Co., Ltd. (Special General Partnership)----

FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.

Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.

Heat List
CN
Overall
Symbol
Price
% Chg

No Data

Investment Theme Medical Device Concept
Medical Device Concept
Intraday+0.57%